Lamark Biotech
Lamark Biotech is dedicated to improving global healthcare through innovative biotech solutions, focusing on thermostable biologics that are refrigeration independent. Their mission is to make essential medicines more accessible and affordable by reducing cold chain dependence, with a vision to enhance the affordability and accessibility of modern medicines worldwide.
Industries
Nr. of Employees
small (1-50)
Lamark Biotech
Products
Thermostable crystalline recombinant human insulin formulation
A crystalline formulation of recombinant human insulin engineered for thermal stability and extended room-temperature shelf life (described as stable for two years at room temperature).
Thermostable crystalline recombinant human insulin formulation
A crystalline formulation of recombinant human insulin engineered for thermal stability and extended room-temperature shelf life (described as stable for two years at room temperature).
Services
Contract R&D for thermostable biologics
Development services for refrigeration-independent formulations of therapeutic proteins, including formulation design, analytical characterization and preclinical proof-of-concept studies.
B2B partnerships for API manufacturing and clinical studies
Partnerships and collaborative programs to support API manufacturing under GMP, conduct clinical studies, and coordinate commercialization activities with pharma partners.
Contract R&D for thermostable biologics
Development services for refrigeration-independent formulations of therapeutic proteins, including formulation design, analytical characterization and preclinical proof-of-concept studies.
B2B partnerships for API manufacturing and clinical studies
Partnerships and collaborative programs to support API manufacturing under GMP, conduct clinical studies, and coordinate commercialization activities with pharma partners.
Expertise Areas
- Thermostable biologics development
- Formulation development and protein crystallization
- Preclinical development and analytical characterization
- GMP process development and scale-up
Key Technologies
- Thermostabilization platform for proteins
- Protein crystallization-based formulations
- Recombinant protein therapeutics
- Preclinical in vivo and analytical models